Activating somatic mutations in PIK3CA are present in ~ 30% of human breast cancers of all stages (Bachman et al., 2004; Barbareschi et al., 2007; Miller, 2012; Saal et al., 2005). Here, PIK3CA is linked to breast carcinoma.